Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection.
J Med Chem
; 59(16): 7696, 2016 08 25.
Article
in En
| MEDLINE
| ID: mdl-27529494
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2016
Type:
Article